Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ACU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -11.16M
March 31, 2026 19.11M
December 31, 2025 -7.131M
September 30, 2025 1.211M
June 30, 2025 -4.654M
March 31, 2025 1.691M
December 31, 2024 -4.899M
September 30, 2024 -5.716M
June 30, 2024 3.109M
March 31, 2024 9.51M
December 31, 2023 -20.03M
September 30, 2023 -7.389M
June 30, 2023 -0.695M
March 31, 2023 -10.32M
December 31, 2022 -7.878M
September 30, 2022 6.135M
June 30, 2022 9.57M
March 31, 2022 6.45M
December 31, 2021 -0.9704M
September 30, 2021 0.748M
June 30, 2021 0.727M
March 31, 2021 1.538M
December 31, 2020 6.754M
September 30, 2020 -5.693M
June 30, 2020 4.756M
Date Value
March 31, 2020 -0.526M
December 31, 2019 -5.781M
September 30, 2019 -2.209M
June 30, 2019 -3.121M
March 31, 2019 0.505M
December 31, 2018 -7.562M
September 30, 2018 1.76M
June 30, 2018 2.583M
March 31, 2018 -2.833M
December 31, 2017 1.024M
September 30, 2017 -1.355M
June 30, 2017 2.181M
March 31, 2017 11.06M
December 31, 2016 -7.105M
September 30, 2016 -2.466M
June 30, 2016 4.219M
March 31, 2016 8.823M
December 31, 2015 -3.35M
September 30, 2015 -1.627M
June 30, 2015 2.684M
March 31, 2015 3.429M
December 31, 2014 -6.245M
September 30, 2014 -0.519M
June 30, 2014 13.96M
March 31, 2014 -5.882M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -1.768B
Abbott Laboratories -3.518B
Align Technology, Inc. -67.45M
AngioDynamics, Inc. -0.108M
Accuray, Inc. 3.624M